Back to search
FDAFDA · Food and drugs·Recall number D-0416-2018

Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01

Published February 21, 2018 · Recall initiated: February 5, 2018

Summary

FDA records drug Class III recall D-0416-2018, published February 21, 2018 and initiated February 5, 2018. Recalling firm: Genentech, Inc.; Status: Terminated; Reported quantity: 3,192 bottles; Lot: Lot # 3141989, EXP 08/31/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genentech, Inc.
Distributor
Distributed throughout the United States
Lot
Lot # 3141989, EXP 08/31/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01 recalled?

Yes. FDA published recall D-0416-2018 on February 21, 2018. Reported hazard: Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.

What should I do if I have this product?

Voluntary: Firm initiated · Letter